Biomedical Engineering Reference
In-Depth Information
Stone GW, Ellis SG, Cox DA
et al. 2004. A polymer-based, paclitaxel eluting stent in patients with
coronary artery disease.
New Engl J Med
350:221-231.
Stone GW, Ellis SG, Cannon L
et al. 2005. the TAXUS V Investigators. Comparison of a polymer-
based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery
disease: A randomized controlled trial.
JAMA
294:1215-1223.
Suzuki T, Kopia G, Hayashi S
et al. 2001. Stent-based delivery of sirolimus reduces neointimal forma-
tion in a porcine coronary model.
Circulation
104:1188-1193.
Tamai H, Igaki K, Kyo E
et al. 2000. Initial and 6-month results of biodegradable poly-l-lactic acid
coronary stents in humans.
Circulation
102:399-404.
Tamai H, Igaki K, Tsuji T
et al. 1999. A biodegradable poly-l-lactic acid coronary stent in porcine
coronary artery.
J Interv Cardiol
12:443-449.
Tarcha PJ, Verlee D, Hui HW
et al. 2007. The application of ink-jet technology for the coating and
loading of drug-eluting stents.
Ann Biomed Eng
35 (10):1791-1799.
Tesfamariam B. 2008. Drug release kinetics from stent device-based delivery systems.
J Cardiovasc
Pharmacol
51:118-125.
Tsuji T, Tamai H, Kyo E. 1998. The effect of PLLA stent design on neointimal hyperplasia.
J Cardiol
32:235A.
Tsuji T, Tamai H, Igaki K
et al. 2001. Biodegradable polymeric stents.
Curr Interv Cardiol Rep
3:10-17.
Udipi K, Melder RJ, Chen M
et al. 2007. The next generation Endeavor Resolute stent: Role of the
BioLinx™ polymer system.
EuroIntervention
3:137-139.
Udipi K, Chen M, Cheng P
et al. 2008. Development of a novel biocompatible polymer system
for extended drug release in a next-generation drug eluting stent.
J Biomed Mater Res
85A:
1064-1071.
Unger F, Westedt U, Hanefeld P
et al. 2007. Poly(ethylene carbonate): Athermoelastic and biodegrad-
able biomaterial for drug eluting stent coatings?
J Control Release
117:312-321.
van der Hoeven BL, Pires NMM, Warda HM
et al. 2005. Drug eluting stents: Results, promises and
problems.
Int J Cardiol
99:9-17.
VanTeeffelen JW, Brands J, Stroes ES
et al. 2007. Endothelial glycoc lyx: Sweet shield of blood vessels.
Trends Cardiovasc Med
17:101-105.
Venkatraman S and Boey F. 2007. Release profiles in drug-eluting stents: Issues and uncertainties.
J
Control Release
120:149-160.
Vert M. 2009. Degradable and bioresorbable polymers in surgery and in pharmacology: Beliefs and
facts.
J Mater Sci MM
20:437-446.
Virmani R, Farb A. 1999. Pathology of in-stent restenosis.
Curr Opin Lipidol
10:499-506.
Vogel J, Sperandio M, Pries AR
et al. 2000. Influence of the endothelial glycocalyx on cerebral blood
flow in mice.
J Cereb Blood Flow Metab
20:1571-1578.
von Recum HA, Cleek RL, Eskin SG
et al
.
1995. Degradation of polydispersed poly(l-lactic acid) to
modulate lactic acid release.
Biomaterials
16:441-447.
Wessely R, Hausleiter J, Michaelis C
et al. 2005. Stent system that allow for dose-adjustable, multiple,
and on-site stent coating.
Arterioscler Thromb Vasc Biol
25:748-753.
Wieneke H, Dirsch O, Sawitowski T
et al. 2003. Synergistic effects of a novel nanoporous
stent coating and tacrolimus on intima proliferation in rabbits.
Catheter Cardiovasc Interv
60:399-407.
Windecker S, Serruys PW, Wandel S
et al. 2008. Biolimus-eluting stent with biodegradable polymer
versus sirolimus-eluting stent with durable polymer for coronary revascularization (LEADERS):
A randomized non-inferiority trial.
Lancet
372:1163-1173.
Wolf KV, Zong Z, Meng J
et al
.
2008. An investigation of adhesion in drug-eluting stent layers.
J
Biomed Mater Res
87A:272-281.
Wright D, Rajalingam B, Selvarasah S
et al. 2007. Generation of static and dynamic pattered co-
cultures using microfabricated parylene-C stencils.
Lab Chip
7:1272-1279.
Zilberman M, Eberhart RC. 2006. Drug-eluting bioresorbable stents for various applications.
Annu
Rev Biomed Eng
8:153-180.
